Konrad Herrmann

Title: Innovations of Konrad Herrmann in Pharmaceutical Chemistry

Introduction

Konrad Herrmann is a notable inventor based in Leipzig, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of new compounds. His work focuses on the synthesis and characterization of polycyclic pyrimidine derivatives, which have potential therapeutic applications.

Latest Patents

Herrmann holds a patent for "Polycyclic pyrimidine-2,4(1H,3H)-diones with functionalized alkyl residues at the 1- and/or 3-position(s); methods for their synthesis and pharmaceutical preparation." This invention details the synthesis of these compounds, their chemical and structural characterization, and the analysis of their physiological and pharmacological activities both in vitro and in vivo. The patent outlines specific synthesis routes and methods for producing these compounds, highlighting their pharmacologically significant collagenase/matrix metalloproteinase inhibitory activities. One specific example presented in the patent is 1-(3-mercaptoprop-1-yl)-3-methyl-chinazolin-2,4(1H,3H)-dione.

Career Highlights

Konrad Herrmann is affiliated with the Private Institute for Biomedical Research and Consulting. His work at this institute has allowed him to explore innovative solutions in the field of biomedicine. With a focus on the synthesis of novel compounds, Herrmann has contributed to advancing pharmaceutical research.

Collaborations

Throughout his career, Herrmann has collaborated with esteemed colleagues such as Petra Wippich and Siegfried Leistner. These collaborations have fostered a productive research environment, leading to significant advancements in their shared field of study.

Conclusion

Konrad Herrmann's contributions to pharmaceutical chemistry through his innovative patents and collaborative efforts highlight his role as a key inventor in the field. His work continues to pave the way for new therapeutic possibilities.